← Open Payments lookup

MINDY RATHE: Open Payments

NPI 1730270117 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$489 in 15 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $192 · 2025 $489

Food & beverage: $489
CompanyPaymentsAmount
Medtronic, Inc.1$165
Sumitomo Pharma America, Inc.5$100
ABBVIE INC.4$82
Astellas Pharma US Inc2$74
Octapharma USA, Inc.1$35
180 Medical, Inc.1$19
Exeltis, USA Inc.1$15

Products named: INTERSTIM, BOTOX, Veozah, MYFEMBREE, GEMTESA, FIBRYGA, SLYND.

Industry payments across NE — which companies pay providers there.